Ovary Cyst Clinical Trial
Official title:
Are the Combined Oral Contraceptive Pills Needed for Management of the Simple Ovarian Cysts in Reproductive Women? (Randomized Controlled Study)
Women will be managed by either of the two modalities and will be followed up by transvaginal
ultrasound monthly for three successive months to evaluate the size and location of the
functional ovarian cyst (follicular), to compare the effect of different modalities of
management whether remission, regression, progression or persistence of functional ovarian
cyst.
The women will be assigned randomly to either study group to take oral contraceptive pills or
to control group to take placebo. The 2 groups will be treated and followed up equally. Oral
contraceptive pills will be given to the study group as follow:
The women will receive one package of oral contraception (Cilest containing norgestimate 250
microgram + ethinyl estradiol 35 microgram) and will be counseled about how to take oral
contraception and informed of possible side effects. They also will receive a diary card for
recording oral contraception intake to be returned to the physician on the next period. An
appointment for the women in this group will be scheduled at one month of treatment for the
second ultra-sonography. If the ovarian cyst does not show remission, the women will continue
the same treatment and will follow up in another month by transvaginal ultra-sound. If the
ovarian cyst still persists or progresses at the second month, the women will be followed up
for third month. All results of the two groups will be compared. Data will be collected,
tabulated according to the standard statistical method.
Women will be managed by either of the two modalities and will be followed up by transvaginal
ultrasound monthly for three successive months to evaluate the size and location of the
functional ovarian cyst (follicular), to compare the effect of different modalities of
management whether remission, regression, progression or persistence of functional ovarian
cyst.
The women will be assigned randomly to either study group to take oral contraceptive pills or
to control group to take placebo. The 2 groups will be treated and followed up equally. Oral
contraceptive pills will be given to the study group as follow:
The women will receive one package of oral contraception (Cilest containing norgestimate 250
microgram + ethinyl estradiol 35 microgram) and will be counseled about how to take oral
contraception and informed of possible side effects. They also will receive a diary card for
recording oral contraception intake to be returned to the physician on the next period. An
appointment for the women in this group will be scheduled at one month of treatment for the
second ultra-sonography. If the ovarian cyst does not show remission, the women will continue
the same treatment and will follow up in another month by transvaginal ultra-sound. If the
ovarian cyst still persists or progresses at the second month, the women will be followed up
for third month. All results of the two groups will be compared. Data will be collected,
tabulated according to the standard statistical method.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04191603 -
TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY
|
N/A | |
| Recruiting |
NCT04817449 -
Spectroscopy in Ovarian Cancer
|
||
| Not yet recruiting |
NCT03585309 -
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cysts.
|
N/A | |
| Recruiting |
NCT05751681 -
Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSI
|
N/A |